Drug profile · INN
sodium oxybate
XYREM
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
sodium oxybate (XYREM) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN sodium oxybate
Brand XYREM
Route ORAL
Formulation FOR SUSPENSION, EXTENDED RELEASE
ATC code N07XX04
Originator Amneal Pharma Europe Ltd
Related patents
Search patents →Frequently asked questions
What is sodium oxybate?
sodium oxybate (XYREM) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sodium oxybate?
XYREM is a marketed brand name for sodium oxybate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sodium oxybate?
sodium oxybate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.